Carl Zeiss Meditec, Inc.
$938.6K 737 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Consortium of Independent Immunology Clinics, LLC
Consortium of Independent Immunology Clinics, LLC reported $938,845.65 across General Payments, Research, and Ownership to 91 physicians and teaching hospitals across 140 transactions.
- $938.8K Above-median payer
- All-tracks total
- 140 Below-median volume
- Transactions
- 91 Below-median reach
- Recipients
- #634
- of 1,925 companies
Consortium of Independent Immunology Clinics, LLC reported $938,845.65 across all CMS Open Payments tracks (General + Research + Ownership) to 91 physicians and teaching hospitals in Program Year 2024 - ranking #634 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $225,283.88, averaging $10.3K per recipient.
How Consortium of Independent Immunology Clinics, LLC's $938.8K all-tracks total breaks down
Consortium of Independent Immunology Clinics, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
19/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer consortium-of-independent-immunology-clinics-llc Consortium of Independent Immunology Clinics, LLC
$938.8K · #634/1,925 · 0.0% industry · PY2024
- TOT $938.8K
- RANK #634
- SHARE 0.0%
- TXN 140
- RCP 91
- CAT 4
- GEN $225.3K
- TOP1 64.5%
- PY 2024
Volume peers
Nearest volume peer: Carl Zeiss Meditec, Inc. ($938.6K)
Consortium of Independent Immunology Clinics, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Consortium of Independent Immunology Clinics, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Consortium of Independent Immunology Clinics, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
28 transactions worth $160.9K make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 71.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Consortium of Independent Immunology Clinics, LLC's 4-category general-payment breakdown at $160.9K, 71.4% of the reported total.
Consortium of Independent Immunology Clinics, LLC reports 4 general-payment categories - the top three are Consulting Fee (71.4%), Honoraria (19.5%), and Travel and Lodging (5.5%). The remaining 1 category make up 3.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Consortium of Independent Immunology Clinics, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $160.9K | 28 | 71.4% |
| Honoraria | $44.0K | 22 | 19.5% |
| Travel and Lodging | $12.3K | 20 | 5.5% |
| Food and Beverage | $8.1K | 21 | 3.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $190,044.72 (84.4%) of $225,283.88 in this company's General Payments records across 26 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Consortium of Independent Immunology Clinics, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Maeve O'Connor
$145,293.30 across 28 reported transactions
- 2
James Tracy
$13,869.11 across 10 reported transactions
- 3
William Lumry
$10,440.99 across 7 reported transactions
- 4
Jason Raasch
$10,400.00 across 6 reported transactions
- 5
Tidence Prince
$10,041.32 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Consortium of Independent Immunology Clinics, LLC's spend rank (#634 of 1,925, top 33% by spend) and concentration rank (#429 of 1,838, top 23% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Joline Medical Inc : $2.6K total payments, HHI 4318
- Cepheid : $408.4K total payments, HHI 4315
- Hoya Surgical Optics, Inc : $11.7K total payments, HHI 4312
- PolarisAR Inc : $22.6K total payments, HHI 4312
- Medicem Inc. : $119.3K total payments, HHI 4304
- Oasis Medical, Inc. : $94.3K total payments, HHI 4288
- Consortium of Independent Immunology Clinics, LLC (this company) : $225.3K total payments, HHI 4285
- Evolved By Nature, Inc. : $239.3K total payments, HHI 4275
- Cochlear Ltd : $10.1K total payments, HHI 4273
- Change Healthcare Technologies, LLC : $89.9K total payments, HHI 4271
- Owens & Minor Distribution, Inc. : $316.70 total payments, HHI 4269
- Nucletron Operations B.V. : $108.4K total payments, HHI 4229
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Consortium of Independent Immunology Clinics, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Consortium of Independent Immunology Clinics, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Consortium of Independent Immunology Clinics, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
NS Pharma, Inc.
$942.1K 369 recipients
Compare payment profiles
Leica Microsystems Inc.
$942.6K 487 recipients
Compare payment profiles
Vascular Technology, Inc.
$943.2K 50 recipients
Compare payment profiles
OrganOx Ltd
$944.6K 100 recipients
Compare payment profiles
Heron Therapeutics, Inc.
$945.0K 4,695 recipients
Compare payment profiles
Put this to use
Consortium of Independent Immunology Clinics, LLC ranks #634 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Consortium of Independent Immunology Clinics, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Consortium of Independent Immunology Clinics, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.